Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates

被引：5
|
作者：
Majoros, L [1 ]
Kardos, G [1 ]
Feiszt, P [1 ]
Szabó, B [1 ]
机构：
[1] Univ Debrecen, Dept Med Microbiol, Med & Hlth Sci Ctr, Debrecen, Hungary
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2005年 / 56卷 / 01期
关键词：
minimal fungicidal concentration; Etest; Fungitest;
D O I：
10.1093/jac/dki174
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [1] In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined
    Szabo, Zsuzsanna
    Soczo, Georgina
    Miszti, Cecilia
    Hermann, P.
    Rozgonyi, F.
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2008, 55 (01) : 53 - 61
  • [2] Caspofungin activity against clinical isolates of fluconazole-resistant Candida
    Pfaller, MA
    Messer, SA
    Boyken, L
    Rice, C
    Tendolkar, S
    Hollis, RJ
    Diekema, DJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) : 5729 - 5731
  • [3] The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates
    Nunes Mario, Debora Alves
    Denardi, Laura Bedin
    Bandeira, Laissa Arevalo
    Antunes, Milene Silva
    Santurio, Janio Morais
    Severo, Luiz Carlos
    Alves, Sydney Hartz
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2012, 107 (03): : 433 - 436
  • [4] Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections
    Girmenia, C
    Venditti, M
    Martino, P
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (03) : 227 - 231
  • [5] Activities of Nanoparticles Against Fluconazole-Resistant Candida parapsilosis in Clinical Isolates
    Lotfali, Ensieh
    Ghasemi, Reza
    Fattahi, Azam
    Keymaram, Mahyar
    Shafiei, Mohammad
    Norouzi, Maryam
    Ayatollahi, Azin
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2021, 19 (08) : 501 - 507
  • [6] In vitro activity of isavuconazole against fluconazole-resistant clinical isolates of Candida auris
    Miranda-Cadena, K.
    San-Millan, R.
    Marcos-Arias, C.
    Ruiz-Gaitan, A. C.
    Peman, J.
    Mateo, E.
    Eraso, E.
    Quindos, G.
    MYCOSES, 2017, 60 : 66 - 66
  • [7] In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species
    Nishi, Isao
    Sunada, Atsuko
    Toyokawa, Masahiro
    Asari, Seishi
    Iwatani, Yoshinori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (01) : 1 - 5
  • [8] Candida inconspicua and Candida norvegensis two fluconazole-resistant pathogens difficult to differentiate
    Guitard, J.
    Angoulvant, A.
    Letscher, V.
    l'Ollivier, C.
    Cornet, M.
    Dalle, F.
    Hennequin, C.
    MYCOSES, 2011, 54 : 98 - 98
  • [9] Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua
    Essayag, SM
    Baily, GG
    Denning, DW
    Burnie, JP
    INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1996, 46 (01): : 35 - 40
  • [10] Synergistic Activity of Chloroquine with Fluconazole against Fluconazole-Resistant Isolates of Candida Species
    Li, Yali
    Wan, Zhe
    Liu, Wei
    Li, Ruoyu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1365 - 1369
12345